When Roche previewed the Axelios technology in February, a Jefferies analyst called the next-generation sequencing platform ...

For decades, formalin-fixing paraffin-embedding has been the preferred method for preserving biological samples for diagnostic research. Formalin is relatively inexpensive and can be used to preserve ...

Pattern of resistance on first-line EGFR-directed therapy in EGFR-positive metastatic non-small cell lung cancer. Utilizing TP53 mutation status and initial disease burden at presentation to ...

The rarity of sarcoma complicates clinical trial design and biomarker-driven treatment, explains Alexander Spira, MD, PhD, ...

The landscape of next-generation sequencing (NGS) continues to be defined by astonishing technological progress. We continue to witness sequencer throughput expansion with systems like the Illumina ...

Asia-Pacific emerges as a key growth region. The global DNA diagnostics market is projected to grow from $13.2b in 2025 to ...

Prospective real world data evaluation of clinical outcomes in metastatic hormone sensitive prostate cancer (MHSPC) patients treated as part of triplet therapy with darolutamide: UK multicenter ...

MiDOG Animal Diagnostics, a leader in next-generation sequencing-based veterinary diagnostics, today announced the launch of MiDOG Parasite-Only Testing, a first-of-its-kind dedicated NGS-based ...

Although next-generation sequencing (NGS) keeps giving—exploring the human genome and revolutionizing our knowledge of health and disease—it needs to take a little, too. At the very least, NGS ...